GSK Secures EU Approval for Simplified Shingrix Presentation in Prefilled Syringe
GSK plc announced that the European Commission (EC) has approved a new prefilled syringe presentation of Shingrix, the company’s recombinant zoster vaccine (RZV), aimed at simplifying administration for healthcare professionals across the European Union.
Simplified Shingrix Presentation In Prefilled Syri | 08/01/2026 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy